SEARCH

SEARCH BY CITATION

References

  • 1
    Chiti F & Dobson CM (2006) Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem 75, 333366.
  • 2
    Selkoe DJ (1991) The molecular pathology of Alzheimer’s disease. Neuron 6, 487498.
  • 3
    Westermark P (2005) Aspects on human amyloid forms and their fibril polypeptides. FEBS J 272, 59425949.
  • 4
    Naiki H, Higuchi K, Hosokawa M & Takeda T (1989) Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavine T. Anal Biochem 177(2), 244249.
  • 5
    Klunk WE, Pettergrew JW & Abraham DJ (1995) Quantitative evaluation of congo red binding to amyloid-like proteins with a beta-pleated sheet conformation. J Histochem Cytochem 37, 12731281.
  • 6
    Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, Morgan TE, Rozovsky I, Trommer B, Viola KL et al. (1998) Diffusible, nonfibrillar ligands derived from Abeta1–42 are potent central nervous system neurotoxins. Proc Natl Acad Sci USA 95, 64486453.
  • 7
    Yankner BA & Lu T (2009) Amyloid beta-protein toxicity and the pathogenesis of Alzheimer disease. J Biol Chem 284, 47554759.
  • 8
    Roychaudhuri R, Yang M, Hoshi MM & Teplow DB (2009) Amyloid β-protein assembly and Alzheimer disease. J Biol Chem 284, 47494753.
  • 9
    Sorgjerd K, Klingstedt T, Lindgren M, Kågedal K & Hammarström P (2008) Prefibrillar transthyretin oligomers and cold stored native tetrameric transthyretin are cytotoxic in cell culture. Biochem Biophys Res Comm 377, 10721078.
  • 10
    Zako T, Sakono M, Hashimoto N, Ihara M & Maeda M (2009) Bovine insulin filaments induced by reducing disulfide bonds show a different morphology, secondary structure, and cell toxicity from intact insulin amyloid fibrils. Biophys J 96, 33313340.
  • 11
    Frare E, Mossuto MF, de Laureto PP, Tolin S, Menzer L, Dumoulin M, Dobson CM & Fontana A (2009) Characterization of oligomeric species on the aggregation pathway of human lysozyme. J Mol Biol 387, 1727.
  • 12
    Baskakov IV & Bocharova OV (2005) In vitro conversion of mammalian prion protein into amyloid fibrils displays unusual features. Biochemistry 44, 23392348.
  • 13
    Bucciantini M, Giannoni E, Chiti F, Baroni F, Formigli L, Zurdo J, Taddei N, Ramponi G, Dobson CM & Stefani M (2002) Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416, 507511.
  • 14
    Wiréhn J, Carlsson K, Herland A, Persson E, Carlsson U, Svensson M & Hammarstrom P (2005) Activity, folding, misfolding, and aggregation in vitro of the naturally occurring human tissue factor mutant R200W. Biochemistry 44, 67556763.
  • 15
    Dobson CM (1999) Protein misfolding, evolution and disease. Trends Biochem Sci 24, 329332.
  • 16
    Hammarstrom P, Jiang X, Hurshman AR, Powers ET & Kelly JW (2002) Sequence-dependent denaturation energetics: a major determinant in amyloid disease diversity. Proc Natl Acad Sci USA 99, 1642716432.
  • 17
    Fernandez-Escamilla AM, Rousseau F, Schymkowitz J & Serrano L (2004) Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins. Nat Biotechnol 22, 13021306.
  • 18
    LeVine H (1993) Thioflavine T interaction with synthetic Alzheimer’s disease B-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci 2, 404410.
  • 19
    Clements A, Walsh DM, Williams CH & Allsop D (1993) Effects of the mutations Glu22 to Gln and Ala21 to Gly on the aggregation of a synthetic fragment of the Alzheimer’s amyloid β/A4 peptide. Neurosci Lett, 161, 1720.
  • 20
    Walsh DM, Lomakin A, Benedek GB, Condron MM & Teplow DB (1997) Amyloid b-protein fibrillogenesis – detection of a protofibrillar intermediate. J Biol Chem 272, 2236422372.
  • 21
    Petkova AT, Ishii Y, Balbach JJ, Antzutkin ON, Leapman RD, Delaglio F & Tycko R (2002) A structural model for Alzheimer’s beta-amyloid fibrils based on experimental constraints from solid state NMR. Proc Natl Acad Sci USA 99, 1674216747.
  • 22
    Jayasinghe SA & Langen R (2004) Identifying structural features of fibrillar islet amyloid polypeptide using site-directed spin labeling. J Biol Chem 279, 4842048425.
  • 23
    Makin OS, Atkins E, Sikorski P, Johansson J & Serpell LC (2005) Molecular basis for amyloid fibril formation and stability. Proc Natl Acad Sci USA 102, 315320.
  • 24
    Nelson R, Sawaya MR, Balbirnie M, Madsen AØ, Riekel C, Grothe R & Eisenberg D (2005) Structure of the cross-beta spine of amyloid-like fibrils. Nature 435, 773778.
  • 25
    Szabo Z, Klement KJ, Zarándi M, Soós K & Penke B (1999) An FT-IR study of the β-amyloid conformation: standardization of aggregation grade. Biochem Biophys Res Comm 265, 297300.
  • 26
    Vestergaard B, Groenning M, Roessle M, Kastrup JS, van de Weert M, Flink JM, Frokjaer S, Gajhede M & Svergun DI (2007) A helical structural nucleus is the primary elongating unit of insulin amyloid fibrils. PLoS Biol 5(5), e134.
  • 27
    Westermark GT, Johnson KH & Westermark P (1999) Staining methods for identification of amyloid in tissue. Methods Enzymol 309, 325.
  • 28
    Hintersteiner M, Enz A, Frey P, Jaton A-L, Kinzy W, Kneuer R, Neumann U, Rudin M, Staufenbiel M, Stoeckli M et al. (2005) In vivo detection of amyloid-β deposits by near-infrared imaging using an oxazine-derivative probe. Nat Biotechnol 23, 577583.
  • 29
    Klunk WE, Wang Y, Huang GF, Debnath ML, Holt DP & Mathis CA (2001) Uncharged thioflavin-T derivatives bind to amyloid-beta protein with high affinity and readily enter the brain. Life Sci 69, 14711484.
  • 30
    Schmidt ML, Schuck T, Sheridan S, Kung MP, Kung H, Zhuang ZP, Bergeron C, Lamarche JS, Skovronsky D, Giasson BI et al. (2001) The fluorescent congo red derivative,trans,trans)-1-bromo-2,5-bis-(3-hydroxycarbonyl- 4-hydroxy)styrylbenzene (BSB), labels diverse beta-pleated sheet structures in postmortem human neurodegenerative disease brains. Am J Pathol 159, 937943.
  • 31
    Nilsson KPR (2009) Small organic probes as amyloid specific ligands – past and recent molecular scaffolds. FEBS Lett, doi:10.1016/j.febslet.2009.04.016.
  • 32
    Groenning M (2009) The binding modes of thioflavin T and congo red in the context of amyloid fibrils. J Chem Biol, doi:10.1007/s12154-009-0027-5.
  • 33
    Lindgren M, Sorgjerd K & Hammarstrom P (2005) Detection and characterization of aggregates, prefibrillar amyloidogenic oligomers, and protofibrils using fluorescence spectroscopy. Biophys J 88, 42004212.
  • 34
    Sakono M, Zako T, Ueda H, Youda M & Mizuo M (2008) Formation of highly toxic soluble amyloid beta oligomers by the molecular chaperone prefoldin. FEBS J 275, 59825993.
  • 35
    Allsop D, Swanson L, Moore S, Davies Y, York A, El-Agnaf OMA & Soutar I (2001) Fluorescence anisotropy: a method for early detection of Alzheimer b-peptide (Ab) aggregation. Biochem Biophys Res Comm 285, 5863.
  • 36
    Luk KC, Hyde EG, Trojanowski JQ & Lee VM–Y (2007) Sensitive fluorescence polarization technique for rapid screening of α-synuclein oligomerization/fibrillization inhibitors. Biochemistry 46, 1252212529.
  • 37
    Hammarstrom P, Persson M, Freskgård P–O, Mårtensson L–G, Andersson D, Jonsson B-H & Carlsson U (1999) Structural mapping of an aggregation nucleation site in a molten globule intermediate. J Biol Chem 274, 3289732903.
  • 38
    Krishnan R & Lindquist SL (2005) Structural insights into a yeast prion illuminate nucleation and strain diversity. Nature 435, 765772.
  • 39
    Christensen PA, Pedersen JS, Christiansen G & Otzen DE (2008) Spectroscopic evidence for the existence of an obligate pre-fibrillar oligomer during glucagon fibrillation. FEBS Lett 582, 13411345.
  • 40
    Thirunavukkuarasu S, Jares-Erijman EA & Jovin TM (2008) Multiparametric fluorescence detection of early stages in the amyloid protein aggregation of pyrene-labeled alpha-synuclein. J Mol Biol 378, 10641073.
  • 41
    Ryan TM, Howlett GJ & Bailey MF (2009) Fluorescence detection of a lipid-induced tetrameric intermediate in amyloid fibril formation by apolipoprotein C-II. J Biol Chem 283, 3511835128.
  • 42
    Orte A, Birkett NR, Clarke RW, Devlin GL, Dobson CM & Klenerman D (2008) Direct characterization of amyloidogenic oligomers by single-molecule detection. Proc Natl Acad Sci USA 105, 1442414429.
  • 43
    Orte A, Clarke R, Balasubramanian S & Klenerman D (2006) Determination of the fraction and stoichiometry of femtomolar levels of biomolecular complexes in an excess of monomer using single-molecule, two-color coincidence detection. Anal Chem 78, 77077715.
  • 44
    Santos AN, Torkler S, Nowak D, Schlittig C, Goerdes M, Lauber T, Trischmann L, Schaupp M, Penz M, Tiller FW et al. (2007) Detection of amyloid-beta oligomers in human cerebrospinal fluid by flow cytometry and fluorescence resonance energy transfer. J Alzheimer’s Dis 11, 117125.
  • 45
    Nilsson KPR, Herland A, Hammarström P & Inganäs O (2005) Conjugated polyelectrolytes: conformation-sensitive optical probes for detection of amyloid fibril formation. Biochemistry 44, 37183724.
  • 46
    Nilsson KPR, Olsson JDM, Stabo-Eeg F, Lindgren M, Konradsson P & Inganas O (2005) Chiral recognition of a synthetic peptide using enantiomeric conjugated polyelectrolytes and optical spectroscopy. Macromolecules 38, 68136821.
  • 47
    Åslund A, Herland A, Hammarström P, Nilsson KPR, Jonsson B-H & Konradsson P (2007) Studies of luminescent conjugated polythiophene derivatives: enhanced spectral discrimination of protein conformational states. Bioconjug Chem 18, 18601868.
  • 48
    Åslund A, Nilsson KPR & Konradsson P (2009) Fluorescent oligo and poly-thiophenes and their utilization for recording biological events of diverse origin – when organic chemistry meets biology. J Chem Biol Published online 02 Aug, 2009; DOI 10.1007/s12154-009-0024-8.
  • 49
    Sigurdson CJ, Nilsson KPR, Hornemann S, Manco G, Polymenidou M, Schwarz P, Leclerc M, Hammarström P, Wüthrich K & Aguzzi A (2007) Prion strain discrimination using luminescent conjugated polymers. Nat Methods 12, 10231030.
  • 50
    Sigurdson CJ, Nilsson KPR, Hornemann S, Heikenwalder M, Manco G, Schwarz P, Ott D, Rülicke T, Liberski PP, Julius C et al. (2009) De novo generation of a transmissible spongiform encephalopathy by mouse transgenesis. Proc Natl Acad Sci USA 106, 304309.
  • 51
    Nilsson KPR, Åslund A, Berg I, Nyström S, Konradsson P, Herland A, Inganäs O, Stabo-Eeg F, Lindgren M, Westermark GT et al. (2007) Imaging distinct conformational states of amyloid-beta fibrils in Alzheimer’s disease using novel luminescent probes. ACS Chem Biol 2, 553560.
  • 52
    Nilsson KPR, Hammarström P, Ahlgren F, Herland A, Schnell EA, Lindgren M, Westermark GT & Inganäs O (2006) Conjugated polyelectrolytes – conformation-sensitive optical probes for staining and characterization of amyloid deposits. Chembiochem 7, 10961104.
  • 53
    Stabo-Eeg F, Lindgren M, Nilsson KPR, Inganas O & Hammarstrom P (2007) Quantum efficiency and two-photon absorption cross-section of conjugated polyelectrolytes used for protein conformation measurements with applications on amyloid structures. Chem Phys 336, 121126.
  • 54
    Jung JC, Mehta AD, Aksay E, Stepnoski R & Schnitzer MJ (2004) In vivo mammalian brain imaging using one- and two-photon fluorescence microendoscopy. J Neurophysiol 92, 31213133.
  • 55
    Klunk WE, Bacskai BJ, Mathis CA, Kajdasz ST, McLellan ME, Frosch MP, Debnath ML, Holt DP, Wang Y-M & Hyman BT (2002) Imaging Abeta plaques in living transgenic mice with multiphoton microscopy and methoxy-X04, a systemically administered Congo red derivative. J Neuropathol Exp Neurol 61, 797805.
  • 56
    Åslund A, Sigurdson CJ, Klingstedt T, Grathwohl S, Bolmont T, Dickstein DL, Glimsdal E, Prokop S, Lindgren M, Konradsson P et al. (2009) Novel pentameric thiophene derivatives for in vitro and in vivo optical imaging of a plethora of protein aggregates in cerebral amyloidoses. ACS Chem Biol 4, 673684.